Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(2)

Detailed Status

Completed2
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed250%
active_not_recruiting125%
recruiting125%

Recent Activity

2 active trials
Showing 4 of 4
recruiting

Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasms

NCT06169163
active_not_recruitingnot_applicable

eNose-TB: Electronic Nose for Tuberculosis Screening

NCT04567498
completednot_applicable

Genosvid Diagnostic Test for Early Detection of COVID-19

NCT04558372
completed

Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation

NCT01182155

Clinical Trials (4)

Showing 4 of 4 trials
NCT06169163

Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasms

Recruiting
NCT04567498Not Applicable

eNose-TB: Electronic Nose for Tuberculosis Screening

Active Not Recruiting
NCT04558372Not Applicable

Genosvid Diagnostic Test for Early Detection of COVID-19

Completed
NCT01182155

Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4